A Phase 4, Randomized, Double blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults with a History of inadequate Response to Oral Preventive Medications
Year: 2023
Type: Device
Phase: IV
Indication: Migraine
A Pilot Study Assessing Preliminary Safety and Efficacy of The ShiraTronics Migraine Therapy System in RELIEVing, Interrupting, and Preventing Chronic Migraine (RELIEV-CM).
